Tansey, EM; Christie, DA; (1998) Drugs in psychiatric practice. In: Tansey, EM and Christie, DA and Reynolds, LA, (eds.) Wellcome Witnesses to Twentieth Century Medicine, vol. 2. (133 - 207). Wellcome Trust: London.
Full text not available from this repository.
The scientific development and clinical use of drugs for the treatment of psychiatric disorders over the past forty years were considered by the Seminar, led by Dr David Healy. Basic work on the mechanisms of drug action and the impact of drugs in psychiatric practice, particularly for the treatment of depression, anxiety, obsessive compulsive disorder and schizophrenia, were discussed. The role of the pharmaceutical industry in developing and promoting new drugs, and the role of new drugs in promoting new disease classifications were reviewed at some length. Subjects as diverse as drug standardization and clinical trials, the creation of specialist scientific societies, tensions between clinical and scientific psychopharmacologists, and the importance of international conferences all emerged during the meeting. This is the third annotated transcript of a collection of four Witness Seminar meetings held between 1996 and 1997, published in volume 2 of Wellcome Witnesses to Twentieth Century Medicine, which includes: Making the Human Body Transparent: The Impact of Nuclear Magnetic Resonance and Magnetic Resonance Imaging (glossary); Research in General Practice (1 graph); Drugs in Psychiatric Practice (glossary); The MRC Common Cold Unit (1 chart and glossary).
|Title:||Drugs in psychiatric practice|
|Keywords:||witness seminar, psychopharmacology, history of medicine|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Life Sciences > Biosciences (Division of) > UCL Centre for the History of Medicine|
Archive Staff Only: edit this record